NCT06271629

Brief Summary

The preservation surgery of the anal sphincter has become a standard procedure for the treatment of rectal cancer and is now possible even when the tumor is close to the anus, thanks to the advancement of surgical techniques. This procedure allows patients to avoid a permanent artificial anus and enables them to evacuate through the anus, maintaining the continuity of the intestine, making it a highly preferred surgical option. Additionally, advancements in tumor treatments have led to improved long-term survival rates. However, this anal sphincter preservation surgery inevitably can cause functional abnormalities in the rectum, and around 90% of patients experience changes in bowel habits after surgery. The characteristic symptoms occurring after rectal cancer surgery, such as diarrhea, urgency of bowel movements, frequent bowel movements, and fecal incontinence, are referred to as Anterior Resection Syndrome (ARS). Particularly, symptoms following low anterior resection surgery for lower rectal cancer are termed Low Anterior Resection Syndrome (LARS). These symptoms are most severe immediately after surgery, persisting up to 1-2 years, with some improvement over time. However, in many patients, LARS can remain a lifelong challenge, significantly impacting their quality of life. Currently, there is no definitive method to treat LARS, and symptom management is achieved through empirical treatment methods or medications. Many patients with LARS experience these symptoms predominantly at night, and it is presumed that their sleep quality is severely compromised, significantly affecting their overall quality of life. However, there is a lack of research on the prevalence of such patients and the appropriate treatments for them.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Feb 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 26, 2022

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2023

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

February 4, 2024

Completed
18 days until next milestone

First Posted

Study publicly available on registry

February 22, 2024

Completed
7 days until next milestone

Study Completion

Last participant's last visit for all outcomes

February 29, 2024

Completed
Last Updated

March 26, 2024

Status Verified

February 1, 2024

Enrollment Period

1.8 years

First QC Date

February 4, 2024

Last Update Submit

March 24, 2024

Conditions

Keywords

low anterior resection syndromeinsomnia

Outcome Measures

Primary Outcomes (1)

  • Impairment in the quality of sleep and quality of life in patients with Low Anterior Resection Syndrome (LARS).

    Insomnia Severity Index Score : Sum of Insomnia Severity Index score

    1 Month

Secondary Outcomes (2)

  • European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30)

    1 Month

  • European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-CR29)

    1 Month

Study Arms (2)

Insomnia Severity index Grade 0&1

administered the Insomnia Severity Index (Korean validated version) to patients with Low Anterior Resection Syndrome (LARS) and divided them into two groups based on the severity grade.

Diagnostic Test: Insomnia severity index

Insomnia Severity index Grade 2&3

administered the Insomnia Severity Index (Korean validated version) to patients with Low Anterior Resection Syndrome (LARS) and divided them into two groups based on the severity grade.

Diagnostic Test: Insomnia severity index

Interventions

The ISI score is a self-report questionnaire consisting of 7 items designed to assess the nature, severity, and impact of insomnia.(16) The typical recall period for respondents is the "last month." The evaluated dimensions include the severity of sleep onset, sleep maintenance, and early morning awakening problems, as well as sleep dissatisfaction, interference of sleep difficulties with daytime functioning, noticeability of sleep problems by others, and the distress caused by the sleep difficulties.

Insomnia Severity index Grade 0&1Insomnia Severity index Grade 2&3

Eligibility Criteria

Age19 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients who have undergone low anterior resection surgery following progressive rectal cancer without permanent stoma

You may qualify if:

  • undergone low anterior resection for progressive rectal cancer
  • undergone bowel continence restoration surgery and are between 1 month and 5 years postoperative
  • ability to comprehend and participate in the clinical trial

You may not qualify if:

  • A history of previous surgery for colorectal cancer
  • Recurrent colorectal cancer
  • Concomitant metastatic colorectal cancer
  • Requiring permanent colostomy
  • Underlying conditions not controlled by medical treatment
  • Inflammatory bowel disease
  • Chronic constipation or diarrhea not controlled by medication before surgery
  • Preoperative symptoms of fecal incontinence
  • Preoperative symptoms of bowel leakage
  • Allergies to the investigational drug
  • Deemed unsuitable for participation in the clinical trial by the principal investigator and study staff

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Seoul National University Hospital

Seoul, South Korea

Location

MeSH Terms

Conditions

Rectal NeoplasmsLow Anterior Resection SyndromeSleep Initiation and Maintenance Disorders

Condition Hierarchy (Ancestors)

Colorectal NeoplasmsIntestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesIntestinal DiseasesRectal DiseasesColonic DiseasesPostoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsSleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System DiseasesMental Disorders

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 4, 2024

First Posted

February 22, 2024

Study Start

February 26, 2022

Primary Completion

November 30, 2023

Study Completion

February 29, 2024

Last Updated

March 26, 2024

Record last verified: 2024-02

Data Sharing

IPD Sharing
Will not share

Locations